| Isolation, differentiation, and characterization of mesenchymal stem cells from human bone marrow K Baghaei, SM Hashemi, S Tokhanbigli, AA Rad, H Assadzadeh-Aghdaei, ... Gastroenterology and hepatology from bed to bench 10 (3), 208, 2017 | 160 | 2017 |
| Global landscape of SARS-CoV-2 mutations and conserved regions MH Abbasian, M Mahmanzar, K Rahimian, B Mahdavi, S Tokhanbigli, ... Journal of Translational Medicine 21 (1), 152, 2023 | 58 | 2023 |
| Mutations in SARS-CoV-2 structural proteins: a global analysis M Abavisani, K Rahimian, B Mahdavi, S Tokhanbigli, ... Virology Journal 19 (1), 220, 2022 | 56 | 2022 |
| Exosomes as a novel cell‐free therapeutic approach in gastrointestinal diseases K Baghaei, S Tokhanbigli, H Asadzadeh, S Nmaki, M Reza Zali, ... Journal of cellular physiology 234 (7), 9910-9926, 2019 | 55 | 2019 |
| Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis K Baghaei, S Mazhari, S Tokhanbigli, G Parsamanesh, H Alavifard, ... Drug discovery today 27 (4), 1044-1061, 2022 | 49 | 2022 |
| Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis S Mazhari, A Gitiara, K Baghaei, B Hatami, RE Rad, A Asadirad, ... European Journal of Pharmacology 882, 173263, 2020 | 23 | 2020 |
| Immunoregulatory impact of human mesenchymal-conditioned media and mesenchymal derived exosomes on monocytes S Tokhanbigli, K Baghaei, A Asadirad, SM Hashemi, ... Molecular Biology Research Communications 8 (2), 79, 2019 | 19 | 2019 |
| SARS‐CoV‐2 Non-structural protein 1 (NSP1) mutation virulence and natural selection: Evolutionary trends in the six continents SS Ghaleh, K Rahimian, M Mahmanzar, B Mahdavi, S Tokhanbigli, ... Virus research 323, 199016, 2023 | 12 | 2023 |
| SARS-CoV-2 NSP3, NSP4 and NSP6 mutations and Epistasis during the pandemic in the world: evolutionary trends and natural selections in six continents H fooladinezhad, M Shahidi, M Mahmanzar, B Mahdavi, S Tokhanbigli, ... medRxiv, 2022.05. 22.22275422, 2022 | 12 | 2022 |
| Dendritic cell-based therapy using LY6E peptide with a putative role against colorectal cancer S Tokhanbigli, A Asadirad, K Baghaei, A Piccin, F Yarian, G Parsamanesh, ... ImmunoTargets and Therapy, 95-104, 2020 | 11 | 2020 |
| Gene expression profile of immunoregulatory cytokines secreted from bone marrow and adipose derived human mesenchymal stem cells in early and late passages M Moghadam, S Tokhanbigli, K Baghaei, S Farivar, ... Molecular biology reports 47, 1723-1732, 2020 | 10 | 2020 |
| Contribution of natural killer cells in innate immunity against colorectal cancer Z Ghazvinian, S Abdolahi, S Tokhanbigli, S Tarzemani, A Piccin, ... Frontiers in Oncology 12, 1077053, 2023 | 8 | 2023 |
| Paracrine signals of mesenchymal stem cells induce epithelial to mesenchymal transition in gastric cancer cells P Azizi, S Mazhari, S Tokhanbigli, FN Noukabadi, ED Abkenar, ... Gastroenterology and hepatology from bed to bench 12 (Suppl1), S51, 2019 | 7 | 2019 |
| Development of experimental fibrotic liver diseases animal model by Carbon Tetracholoride A Gitiara, S Tokhanbigli, S Mazhari, K Baghaei, B Hatami, SM Hashemi, ... Gastroenterology and hepatology from bed to bench 10 (Suppl1), S122, 2017 | 6 | 2017 |
| The First Geographic Identification by Country of Sustainable Mutations of SARS-COV2 Sequence Samples: Worldwide Natural Selection Trends M Mahmanzar, ST Houseini, K Rahimian, AM Namini, A Gholamzad, ... bioRxiv, 2022 | 4 | 2022 |
| Imatinib suppresses activation of hepatic stellate cells by targeting STAT3/IL‐6 pathway through miR‐124 H Alavifard, S Mazhari, A Meyfour, S Tokhanbigli, S Ghavami, MR Zali, ... Cell Biology International 47 (5), 969-980, 2023 | 3 | 2023 |
| The effect of mesenchymal stem cells and imatinib on macrophage polarization in rat model of liver fibrosis A Malmir, S Farivar, R Rezaei, S Tokhanbigli, B Hatami, S Mazhari, ... Cell Biology International 47 (1), 135-143, 2023 | 3 | 2023 |
| Fibroblast growth factor 2 reduces endoplasmic reticulum stress and apoptosis in in-vitro Non-Alcoholic Fatty Liver Disease model SP Hosseini, S Farivar, R Rezaei, S Tokhanbigli, B Hatami, MR Zali, ... DARU Journal of Pharmaceutical Sciences 31 (1), 29-37, 2023 | 2 | 2023 |
| Combination of pioglitazone and dendritic cell to optimize efficacy of immune cell therapy in CT26 tumor models S Tokhanbigli, H Alavifard, HA Aghdaei, MR Zali, K Baghaei BioImpacts: BI 13 (4), 333, 2023 | 2 | 2023 |
| Analysis of Whole-Genome Sequencing of SARS-CoV-2 Reveals Recurrent Mutations among Iranian Patients MH Abbasian, B Mahdavi, M Mahmanzar, S Tokhanbigli, MM Sisakht, ... medRxiv, 2022.06. 20.22276625, 2022 | 1 | 2022 |
